... WNT10B 0.4- * 0.3- T 0.2- 12-0 0.0 to be a novel therapeutic target of immunotherapy in ccRCC. Normal Tumor Normal Tumor FIGURE 9 | TAZ / WNT10B was closely ...
確定! 回上一頁